ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane (Q43582187)

24 November 2017

title

ICRF 159, (+/-) 1,2-di(3,5-dioxopiperazin-1-yl) propane NSC-129,943; razoxane (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A821609

30 July 2022

author name string

M. T. Bakowski

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A821609

30 July 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=821609

30 July 2022

publication date

1 June 1976

1 reference

24 November 2017

published in

Cancer Treatment Reviews

1 reference

24 November 2017

volume

3

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

95-107

1 reference

The effect of (±) 1,2-bis(3,5-dioxopiperazin-1-yl) propane (ICRF 159) on liver metastases from a hamster lymphoma

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

1 reference

7 January 2021

Cell Proliferation and the Action of Cytotoxic Agents on Haemopoietic Tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Combination therapy with drugs and radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

The bioavailability in man of ICRF-159 a new oral antineoplastic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Antitumour Activity in a Series of bisDiketopiperazines

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Prenatal effects of the cancer chemotherapeutic drug ICRF 159 in mice, rats, and rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Anti-metastatic effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Cumulative Cytostatic Effect of ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Control of Malignant Metastases by ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Proceedings: Analysis of the antimetastatic action of the antimitotic agent ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

The antitumour activity of a series of benzothiophenes

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Synergism of ICRF 159 and radiotherapy in treatment of experimental tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Preliminary clinical assessment of I.C.R.F. 159 in acute leukaemia and lymphosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943).

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Metastases and the normalization of tumour blood vessels by ICRF 159: a new type of drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Combined treatment of the Walker tumour with radiotherapy and ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

A study of the influence of various diagnostic and therapeutic procedures applied to a murine squamous carcinoma on its metastatic behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

[Radiotherapy and ECRF 159 (NCS 129943) in the treatment of inoperable soft-tissue sarcoma (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Combined treatment of soft tissue and osteosarcomas by radiation and ICRF 159

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Determination of (±)‐1,2‐Bis(3,5‐dioxopiperazinyl) propane Plasma Levels in Rats, Rabbits, and Humans by GLC and Mass Fragmentography

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Mode of Action of the Cytostatic Agent ‘ICRF 159’

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

Proceedings: Mechanism of action studies with IRCF 159: effects on the growth and morphology of BHK-21S cells

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

The study of circulating tumor cells by the formation of pulmonary embolic tumor growths in a secondary host

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

The place of radiotherapy in the management of fibrosarcoma of the soft tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2876%2980007-2

7 January 2021

10.1016/S0305-7372(76)80007-2

Identifiers

DOI

1 reference

24 November 2017

1 reference